A test of 511 AI-designed antibodies shows AI can improve promising drug candidates, but lab experiments remain essential for discovering safe, developable antibodies.

Nxera Pharma, previously known as Sosei Heptares or the Sosei Group, has entered a collaboration and licensing agreement with Antiverse to design antibodies for G-protein coupled receptors (GPCRs).

Affordable custom antibody production supports researchers studying zebrafish, Drosophila, yeast, plants, C. elegans, ...

A receptor-triggered peptide self-assembly strategy converts monomeric hapten conjugates into multivalent antibody-recruiting ...

OpenAI-backed Nabla Bio's JAM-2 AI model designs antibodies ready for human trials, potentially revolutionizing drug ...

Researchers from David Baker's lab (University of Washington) have designed this antibody from scratch to neutralize a deadly toxin from C. difficile. [Ian Haydon] “Life could not exist without ...

Researchers at Texas Biologics at The University of Texas at Austin, working with scientists internationally, have made an important discovery that could improve treatment of human cytomegalovirus ...

When Xaira Therapeutics debuted in 2024 with a gobsmacking $1 billion in funding, a natural expectation would have been for a ...

Antibody therapeutics are a rapidly growing class of drugs used to treat infections as well as a range of diseases. Among them are cancer and autoimmunity particularly important, and the use of ...

Antibodies are popularly used in therapeutics due to their drug-like properties, such as minimal immunogenic effects and increased target selectivity. The first step for the development of an antibody ...

Dong-A ST(170900) said on the 1st that it signed a joint research agreement with the artificial intelligence (AI) new drug ...

Boost ROI through AI-enabled discovery, specialized CRO outsourcing, pipeline optimization, advanced antibody formats, strategic partnerships, licensing and targeted market entry.Dublin, Oct. 01, 2026 ...